Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Kathleen Corey, M.D.

Co-Author

This page shows the publications co-authored by Kathleen Corey and Tracey Simon.
Connection Strength

6.243
  1. Reply. Clin Gastroenterol Hepatol. 2020 02; 18(2):523-524.
    View in: PubMed
    Score: 0.849
  2. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 12; 17(13):2776-2784.e4.
    View in: PubMed
    Score: 0.836
  3. Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction. Obesity (Silver Spring). 2017 08; 25(8):1313-1316.
    View in: PubMed
    Score: 0.740
  4. MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD). Hepatol Commun. 2017 Jul; 1(5):429-438.
    View in: PubMed
    Score: 0.730
  5. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2021 Sep 02.
    View in: PubMed
    Score: 0.246
  6. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis. Metabolism. 2021 07; 120:154780.
    View in: PubMed
    Score: 0.239
  7. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Hepatol Commun. 2021 01; 5(1):133-143.
    View in: PubMed
    Score: 0.232
  8. Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women. Metabolism. 2020 12; 113:154398.
    View in: PubMed
    Score: 0.231
  9. Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis. Gastroenterology. 2020 12; 159(6):2232-2234.e4.
    View in: PubMed
    Score: 0.228
  10. Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV. J Acquir Immune Defic Syndr. 2020 08 01; 84(4):400-404.
    View in: PubMed
    Score: 0.228
  11. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020 04; 51(7):728-736.
    View in: PubMed
    Score: 0.220
  12. Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts. J Hepatol. 2020 06; 72(6):1062-1069.
    View in: PubMed
    Score: 0.219
  13. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma. JAMA Oncol. 2018 12 01; 4(12):1683-1690.
    View in: PubMed
    Score: 0.203
  14. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe. Int J Cardiol. 2018 Nov 01; 270:245-252.
    View in: PubMed
    Score: 0.196
  15. Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis. Int J Cardiol. 2018 05 15; 259:198-204.
    View in: PubMed
    Score: 0.195
  16. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology. 2018 05; 67(5):1797-1806.
    View in: PubMed
    Score: 0.193
  17. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. Dig Dis Sci. 2016 12; 61(12):3425-3435.
    View in: PubMed
    Score: 0.175
  18. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021 11; 6(11):903-913.
    View in: PubMed
    Score: 0.062
  19. Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort. Obesity (Silver Spring). 2021 03; 29(3):595-600.
    View in: PubMed
    Score: 0.059
  20. Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study. Gastroenterology. 2021 04; 160(5):1620-1633.e13.
    View in: PubMed
    Score: 0.058
  21. Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. Clin Gastroenterol Hepatol. 2021 07; 19(7):1480-1488.e14.
    View in: PubMed
    Score: 0.057
  22. The MELD-Plus: A generalizable prediction risk score in cirrhosis. PLoS One. 2017; 12(10):e0186301.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.